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The Clinical Use of Fluorine

in Bone Scanning

R. A. Gastesi, M.D.,* A. T. Vulpetti, B.S.,**
T. L. Kosnik, M.S.,** W. G. Tucker, M.D.* and
R. W. Talley, M.D.*

Roentgenograms are frequently inadequate in the detection of early osseous metastases. Isotope bone scan is a more sensitive diagnostic procedure. Reported here
are findings on 40 patients with known or suspected osseous involvement using the
short-lived radionuclide
"F. Comparison
with standard roentgenograms
and
clinical follow-up demonstrated 11 early detections. '^F was found to be a very
suitable agent for isotope bone scanning. Ilustrative cases are presented.

Standard roentgenograms and tomographic studies frequently fail to detect
early metastatic skeletal involvement
even in patients who are symptomatic.
Therefore, a search was initiated for a
diagnostic method sufficiently sensitive
to ensure the earliest possible detection
of bone metastases. This report describes the clinical observations made
of 40 patients who were given bone
scans with radioactive sodium fluoride
(isp) These observations are correlated with the progression of disease as
demonstrated by means of standard
roentgenography. In a significant number of patients, preliminary studies with
'-"^F revealed skeletal metastatic involvement prior to roentgenographic detection. The determination of osseous
metastases at such an early stage permits the institution of therapy prior to
changes recorded by means of roentgenograms.

Material and Methods
Radioactive sodium fluoride ('*F)
was supplied by the Phoenix Memorial
Laboratory in Ann Arbor. It was produced by irradiating lithium carbonate
in a high density flux of reactor neutrons. In the process, a neutron reacts
with a lithium atom and forms helium
and tritium nuclei [«Li (n, a) -'H], In
turn, the tritium reacts with an oxygen atom from the carbonate to form
a neutron and radioactive fluoride
['«0 (•'H,n)i8F], according to the method of Bernstein and Katz.' Sterile techniques were employed throughout the
process. All chemical and radiochemical impurities were separated and the
following requirements were met: (a)
the lithium content less than 0.6 mg/
100 ml; (b) the lanthanum less than
4.5 mg/100 ml—the lanthanum is used
to coprecipitate the i^F from the solution of LioCOri; and (c) the concentration of tritium (at time of production)
less than 2;uc/0.1 mCi of " F . At the
time of assay, the final product con-
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sists of sodium fluoride in a physiological saline solution.
The scanning agent, '*F, is a shortlived nuclide with a half-life of "109.7
minutes (1.87 hours) which decays to
stable oxygen and, in the process, emits
a 0.65 MeV positron. The positron in
turn immediately annihilates a neighboring electron, producing two 0.51
MeV y rays.- The Picker Magnascanner with a three-inch Nal ( T l ) crystal
and 19-hole focusing collimator was
the instrument used to detect these 7
rays, thus demonstrating '*F concentration in skeletal tissue.
The incorporation of fluoride into
bone seems to depend on exchange of
fluoride ion with the hydroxyl ions not
only at the surfaces but also in the interior of hydroxyapatite crystals of the

bone.'^ This exchange also can occur
with other ions, strontium (Sr) and
calcium (Ca) having a close physiochemical relationship with the fluoropatite of the bone. Evidence also has
been presented by Van Dyke et al*
that the initial distribution of fluoride
in bone is dependent on the blood perfusion rate. The latter dominates because it is a more rapid process.
All 40 patients included in this
study were known to have had a malignancy, though in many instances metastatic disease had not been proved. The
criterion for selection of patients was
histological evidence of primary neoplastic disease with known or suspected
osseous involvement.
Each patient was given '*F orally (1
mCi diluted in water) or intravenous-

TABLE
Fluorine-18 bone scans classified according to the primary neoplastic
site.
Primary
Neoplasia

Patients

Scans

Diagnostic

Non-Diagnostic

Breast
Lung
Prostate
M. myeloma
Colon and rectum
Bladder
Endometrium
Uterine sarcoma
? Primary

19
6
4
3
3
1
1
1
2

26
8
6
3
4
1
1
1
2

23
8
6
3
4
1
1
i
2

3

Totals

40^

52"

49

3
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TABLE II
Correlation of the bone scans and x-ray films In the same patients; classified
by anatomical regions.
Extremities
Upper Lower

Pelvis

1
1

8
1

8
1

3

3

-

14
7
1
10
10
2

1
1

6
2
1

3
4
2

3

3

Scans
-1-

X-ray Films

Vertebral Column
Cerv. Dorsal Lumbar

Results

-I-

+

Chest
Wall
1

1

Early
Detection
ly (750 pCi by acute injection). Our
screening experience at various time intervals agreed with other authors,*- •''
i.e., optimum time for scanning was
one hour after intravenous injection or
one and a half hours after oral administration of the nuclide. Because of the
rapid clearance of '^F from blood by
urinary excretion,* " patients were
asked to void at least once before bone
scanning was started. This reduced the
isotope in the bladder which would
complicate bone-scan interpretation.
The bones to be scanned were selected
after clinical evaluation or equivocal
x-ray films. The scanning time varied
from 30 to 60 minutes depending on
the area being investigated. The scan
was performed either by anterior or
posterior projection or both. The scans
were then compared with previously
obtained x-ray films, plain film, and/

or laminograms. The lesions were confirmed later by subsequent development of obvious osteolytic or osteoblastic lesions in follow-up roentgenograms.
Results
From a total of 52 scans performed
in 40 patients, 49 scans were suitable
for diagnosis (Table 1); the three
considered unsuitable were due to isotope retention in the stomach, an example of which is shown in Fig 1. The
correlation of these bone scans with
roentgenograms obtained within a few
days of scanning is shown in Table I I .
Active lesions were found in the pelvic
area in four patients, three of whom
had negative roentgenograms. A l though the x-ray film of the fourth originally was diagnosed as negative, in
retrospect, it was found to be equivocal
after the scan results. Most of the
109
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Figure 1
Retention of isotope in the stomach three hours following oral administration of i^p.
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early detected lesions in the vertebrae
were found in the lumbar region. Of
the five positive scans obtained of the
lumbar spine, roentgenograms were
negative in three and equivocal in two.
A summary of the eleven patients
in whom the bone scans were positive
and roentgenograms were negative is
listed in Table I I I . Two examples i l lustrative of positive scans with normal
or equivocal roentgenograms are seen
in Figs 2 and 3.
Figure 2. Patient J. S., 48 years of
age with uterine leiomyosarcoma, presented with right hip pain; x-ray films
were equivocal. Her bone scan showed

a distinct increased uptake in the neck
of the right femur. Two months later
she suffered a pathological fracture in
this area and expired the following
month from pulmonary metastases. Autopsy findings confirmed the neoplastic
involvement of the neck of the right
femur.
Figure 3. Patient V.C. had a mastectomy for breast carcinoma in 1966.
She developed low back and left sacroiliac pain of several weeks' duration;
the pain intensified, becoming severe by
early June, 1968. A metastatic bone
survey on 6/5/68 was interpreted as
negative. An '*F bone scan showed in-

TABLE III
Summary of patients with early lesions demonstrating the area of metastatic deposits and
route employed.
Clinical
Symptoms

Results
Area of
X-ray Films-Scan Increase Uptake

Patient

Primary
Neoplasia

V.C.

Breast

Low back pain

CH.

Breast

Low back pain

M.F.

Breast

Lt. hip pain

P.S.

Breast

Low back pain

F.G.

Breast

Thoracic back pain

-I-

L-1, 1-2, T-12

0

E.G.

Breast

Lt. sacro-iliac pain

+

Lt. femoral neck
Rt. F. iliac joint

0

G.C.

Lung

Low back pain

+

T-12, L-1, S-l

0

B.N.

Lung

Low back pain

+

L-2, L-3

A. B.

Prostate

Diffuse cervical
and lumbar pain

R.W.

Colon

Severe pain It. hip
Mod. low back pain

-1-

-1-

J.S.H.

Uterine
sarcoma

Rt. hip pain

+

-\-

+

+

+

L-5, S-l

0

L-4, L-5, S-l

0

Lt. femoral
epiphysis
Lt. sac.-iliac
joint

I.V.

T-11

I.V.

Lt. sacro-iliac

111

Route

L-2, L-3
Rt. femoral neck

I.V.
0
I.V.
0
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ANT.
4 S 68

Figure 2
Above: Anterior pelvic scan demonstrating higher uptake in right neck femur.
Below: Corresponding roentgenogram one week prior to scan.
112

The Clinical Use of Fluorine'^ in Bone Scanning

Figure 3
Above:
Posterior pelvic
scan demonstrating higher
uptake in left
sacro-iliac,
mid-sacrum,
and lumbar
spine.

Below:
Corresponding
roentgenogram.
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cause of its heavy metal toxicity and
the higher soft tissue concentration.
Other investigators have found *"'"Sr a
suitable agent. However, the major disadvantage of the latter agent is its
concentration in the colon which obscures the bones of the pelvis. Our
experience with '^F showed four definite advantages:

creased uptake in the left sacro-iliac
area, mid-sacrum, and lumbar vertebrae. Two interesting findings resulted
from a review of previous and current
roentgenograms and a comparison with
the ^^F bone scan: (1) A discrete osteolytic lesion in the left ilium, present
since October, 1967 had been treated
with cobalt therapy in December, 1967,
and had not changed in eight months.
The bone scan showed no increased
uptake in this area, probably due to
the arrested activity of the lesion by
the cobalt therapy. (2) In the eight
months, October, 1967 to June, 1968,
the only change noted in the roentgenograms was a diffuse decrease of opacity
localized to the left sacro-iliac area,
where the bone scan showed most uptake.

1. Because of its short half-life,
larger doses may be administered
with relatively little radiation to the
patient (estimated dose per millicurie administered is 0.03 rad total
body and 0.23 rad to the bone.^^)
2. The rapid decay and low radiation dose permits serial scanning at
frequent intervals without interference by previous doses.

Similar results were obtained in patients with other neoplastic diseases, as
listed in Table I . We have noted no
direct correlation between the degree
of uptake of the lesion and the primary
site of the malignancy.

3. Since it is rapidly localized in
bone metastases, relatively good differentiation is obtained between
lesion and normal bone.
4. Because there is a higher photon
yield, scans may be obtained in a
shorter period of time.

Discussion

The disadvantages of ^*F as a bone
scanning agent are: (1) the high urinary concentration of the isotope may
confuse scan interpretation along the
lower urinary tract, mainly in the area
of the bladder where an increased uptake of the isotope is usually obtained;
and (2) the necessity of proximity to
the site of production of the nuclide
because of its short half-life of 1.87
hours.
Oral administration was used routinely in the initial evaluation. Three
unsatisfactory scans, due to stomach
retention in patients with functional
disorders of the upper gastrointestinal

Original studies""'^ demonstrated that
the radioactive nuclides, "boneseekers" of calcium 47 (*'Ca) and
strontium 85 (*^Sr), were effective
agents for bone scanning. However,
they had distinct disadvantages. The
high energy of 1.3 MeV of *^Ca and
the high radiation dose delivered to the
bone from ''^Sr (because of its long
half-life—65 days) limited their feasibility for routine clinical use. Thus, particular attention has been placed on the
attractive short-lived nuclides ^^F, ^•''F,
'^^'"Sr, and most recently gallium 68
("'•^Ga). The experience with •'^Ga has
been limited to animal studies®' ^° be114
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tract, prompted the use of the intravenous route. An adequate ratio of
lesion to normal bone activity is obtained by either route. The intravenous
route is preferable in patients with
recent histories of nausea, emesis, or
pylorospasm; in those receiving cytotoxic agents affecting the gastrointestinal tract; and when the area to be
scanned includes the dorsal or lumbar
spine.
Recently. D. A. Weber et aP reported that the optimum time for bone
scanning with " F was between three
and five hours. However, our best results were obtained one hour following
the intravenous administration of the
isotope. We found that after two hours
the count rate was inadequate for
scanning. This difference may be explained by the different resolution, collimation, and scan speed employed; or
perhaps, by the fact that we were
scanning mostly deeper osseous structures (pelvis and vertebrae) in con-

trast to the superficial tibia used by
Weber et al. Our current practice is to
employ '^p scans only in patients with
suspected neoplastic lesions with negative roentgenograms, attempting further
to evaluate the usefulness of this technique in the detection of early lesions
in bone.
Our findings and those of other investigators seem to indicate that ^^p
probably is the isotope of choice for
the detection of early osseous metastases. Results of comparative studies in
the same patients using '^p and other
isotopes will be essential to establish
the definite superiority of any one isotope.
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